Healthcare -
Biotechnology - NASDAQ - US
$ 32.65
0.276 %
$ 3.64 B
Market Cap
-34.73
P/E
VKTX - COST OF REVENUE
Cost of Revenue VKTX - Viking Therapeutics, Inc.
292 K
LAST VALUE
-0.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR